Bausch + Lomb Corporation
CA$28.10-CA$0.65 (-2.26%)
Bausch + Lomb Corporation’s quoted price sits in the upper half of its reported 52-week range, 5.48% below the high.
CNQ · LUFF.CN · CAD
Stock price, earnings
Quote as of Jan 24, 2023, 02:30 PM UTC. Cached market data; not a live quote.
Price history is currently unavailable.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Luff Enterprises Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Luff Enterprises Ltd. operates as a CBD lifestyle brand, specializing in the creation and supply of hemp-derived cannabinoid wellness products across the United States. The company's approach centers on developing formulations that harness specific cannabinoids, such as CBG and CBN, often enhancing these with beneficial superfood ingredients. Its diverse product line includes tinctures, edible gummies, various topicals, capsules, softgels, and creams. Customers can acquire these items directly through the company's dedicated e-commerce site, shop.luffbrands.com. Established in 2013, the organization was previously known as Ascent Industries Corp. before officially adopting the name Luff Enterprises Ltd. in May 2020. The company maintains its corporate headquarters in Vancouver, Canada.
Latest available per-share figures in CAD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:19 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CA$28.10-CA$0.65 (-2.26%)
Bausch + Lomb Corporation’s quoted price sits in the upper half of its reported 52-week range, 5.48% below the high.
CA$0.04+CA$0.01 (+16.67%)
Willow Biosciences Inc.’s quoted price sits in the lower half of its reported 52-week range, 95.17% below the high.
CA$0.01CA$0.00 (0.0%)
Heritage Cannabis Holdings Corp.’s quoted price sits in the lower half of its reported 52-week range, 75.0% below the high.
CA$0.01-CA$0.01 (-33.33%)
Filament Health Corp.’s quoted price sits in the lower half of its reported 52-week range, 85.71% below the high.
CA$0.10-CA$0.04 (-25.93%)
Awakn Life Sciences Corp.: Healthcare · Biotechnology.
CA$0.04CA$0.00 (0.0%)
Empower Clinics Inc.’s quoted price sits in the lower half of its reported 52-week range, 11.11% below the high.
$0.00$0.00 (0.0%)
THC Biomed Intl Ltd.’s quoted price sits in the lower half of its reported 52-week range, 95.92% below the high.
$0.00$0.00 (0.0%)
Body and Mind Inc.’s quoted price sits in the lower half of its reported 52-week range, 98.0% below the high.